Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, wind is a recognised side effect of Wegovy. Bloating, burping and flatulence are among the gut-related effects that many people notice, particularly in the first few weeks on semaglutide or after a dose increase. They tend to ease as the body adjusts. Wegovy is a prescription-only medicine — a prescriber assesses whether it is suitable for you before any treatment begins. This page explains why wind happens, what the pattern usually looks like, and when it is worth mentioning to your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've collected your pen, stored it in the fridge, and given yourself that first injection. A few days in, you notice you're more gassy than usual. Possibly a lot more. This is not a sign something has gone wrong, it is a predictable consequence of how semaglutide works.
Wegovy is a GLP-1 receptor agonist. One of its core mechanisms is slowing gastric emptying: food spends longer in the stomach and moves more slowly through the small intestine. That slower transit gives gut bacteria more time to ferment partially digested carbohydrates, which produces gas. The result can be bloating, excess flatulence, loud burping and a feeling of abdominal fullness that persists well after eating.
The Wegovy patient information lists flatulence, belching and abdominal distension among its recognised side effects, and the NHS medicines guidance for semaglutide confirms burping and wind as part of the gastrointestinal profile you may experience. These symptoms are not dangerous, but they are uncomfortable, and for some people, socially inconvenient enough to feel disruptive.
The pattern almost always follows the same arc: most noticeable in the first seven to fourteen days at a new dose, then gradually settling as the gut adapts. If you have stepped up from 0.5mg to 1.0mg, for instance, expect a similar brief flare before things calm again.
Not everyone experiences the same degree of gassiness, even on identical doses. Several things appear to make a difference. Diet is the most controllable of them. Foods that are already fermentable (onions, garlic, beans, cruciferous vegetables like broccoli and cauliflower) become more gassy still when gastric emptying is slow. Carbonated drinks add literal gas to a system that is already producing more than usual. Eating quickly and swallowing air compounds the problem.
Portion size matters too. Because Wegovy reduces appetite significantly, some people eat smaller meals but graze more frequently, which can keep the gut in a constant slow-transit state. Three structured meals with space between them often produces fewer symptoms than continuous light eating.
There is also an individual variation that cannot be explained entirely by diet. Gut microbiome composition, baseline digestive transit speed, and sensitivity to GI disturbance all vary between people. If you have a history of irritable bowel syndrome or functional gut symptoms, you may find the wind side effect more pronounced than most people expect. That is worth mentioning in your consultation, it does not automatically exclude you from treatment, but a prescriber can factor it into how your dose is titrated.
For a broader look at what other side effects Wegovy can cause, including nausea and constipation, there is a dedicated page that covers the full pattern.
The good news is that this side effect responds well to simple changes. None of them require stopping treatment or waiting out weeks of discomfort.
Eat slowly and chew thoroughly, this reduces swallowed air and gives digestive enzymes more time to work before food reaches the large intestine. Cutting back on fizzy drinks, including sparkling water, removes an obvious source of excess gas. Temporarily reducing high-fermentable foods (the onion-garlic-bean family) during the first few weeks at a new dose can make a noticeable difference for many people; you do not need to cut them out permanently.
Smaller, well-spaced meals are generally better tolerated than large ones. Because semaglutide already reduces how much you want to eat, this usually comes naturally, but consciously spacing meals by three to four hours rather than grazing tends to give the gut recovery time.
Over-the-counter preparations containing simeticone are commonly used for trapped wind and are generally considered safe alongside Wegovy, but check with a pharmacist before adding anything new. Peppermint capsules have reasonable evidence for general wind symptoms, though specific data during GLP-1 treatment is limited. Your prescriber or clinical team is the right person to advise you on whether any specific preparation suits your situation.
If wind is accompanied by severe or persistent abdominal pain (particularly pain that reaches the back) that is a different matter. The MHRA's January 2026 Drug Safety Update highlighted that acute pancreatitis is a known, infrequent but serious side effect of GLP-1 medicines: seek urgent medical attention for severe stomach pain that does not ease, with or without vomiting, rather than attributing it to ordinary wind.
For most people, wind settles into a background nuisance rather than a significant problem once the body has adapted to a dose. Clinical trial data for semaglutide shows that gastrointestinal side effects (including flatulence) cluster in the earlier weeks of treatment and at each dose step, rather than persisting at the same intensity throughout. The STEP 1 trial, published in the New England Journal of Medicine, recorded GI side effects in a meaningful proportion of participants; the majority were mild to moderate and transient.
By the time most people reach their maintenance dose, wind has usually become manageable or resolved, and understanding how long Wegovy is typically used for can help you put that early discomfort in perspective. The treatment's appetite-reducing and weight-management effects tend to persist well beyond the point when gut symptoms have settled. If symptoms remain disruptive for more than a few weeks at a stable dose, that is a conversation for your prescriber, titration pace and supportive advice can both be adjusted.
If you are still weighing up whether Wegovy suits you and want to understand what private treatment costs in the UK, that page sets out the landscape honestly, including what a legitimate price should include. Treatment is a prescription-only commitment, not a purchase, and that framing matters for how you think about the decision.
Wind is rarely the reason someone stops Wegovy. But it is one of the most commonly under-discussed side effects, a question our prescribers hear regularly, usually with a degree of embarrassment that is entirely unwarranted. It is a documented pharmacological effect, and asking about it is the right thing to do. Check your eligibility and start a free consultation if you want to talk through the full side-effect picture with a prescriber before committing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.